Showing 1 - 13 of 13 Items
Showing 1 - 13 of 13 Items
Sort By: Relevance
Journal Article
|Research
2023-02-21 • Open Forum Infectious Diseases
2023-02-21 • Open Forum Infectious Diseases
BACKGROUND
Children and adolescents with household exposure to multidrug- or rifampicin-resistant tuberculosis (MDR/RR-TB) are at high risk of developing TB disease. Tuberculosis pre...
Children and adolescents with household exposure to multidrug- or rifampicin-resistant tuberculosis (MDR/RR-TB) are at high risk of developing TB disease. Tuberculosis pre...
Journal Article
|Letter
2022-10-01 • International Journal of Tuberculosis and Lung Disease
2022-10-01 • International Journal of Tuberculosis and Lung Disease
Journal Article
|Research
2008-08-06 • JAMA
2008-08-06 • JAMA
CONTEXT
Rifampicin-based antitubercular therapy reduces the plasma concentrations of nevirapine and efavirenz. The virological consequences of these interactions are not well describ...
Rifampicin-based antitubercular therapy reduces the plasma concentrations of nevirapine and efavirenz. The virological consequences of these interactions are not well describ...
Journal Article
|Review
2016-05-20 • International Journal of Epidemiology
2016-05-20 • International Journal of Epidemiology
Journal Article
|Research
2014-05-14 • Lancet
2014-05-14 • Lancet
Antiretroviral therapy reduces the risk of tuberculosis, but tuberculosis is more common in people with HIV than in people without HIV. We aimed to assess the effect of isoniazid prevent...
Journal Article
|Research
2010-02-20 • AIDS
2010-02-20 • AIDS
OBJECTIVES: We report on outcomes after 7 years of a community-based antiretroviral therapy (ART) programme in Khayelitsha, South Africa, with death registry linkages to correct for mort...
Journal Article
|Research
2012-09-05 • Clinical Infectious Diseases
2012-09-05 • Clinical Infectious Diseases
Current symptom screening algorithms for intensified tuberculosis case finding or prior to isoniazid preventive therapy (IPT) in patients infected with human immunodeficiency virus (HIV)...
Journal Article
|Commentary
2022-03-01 • Lancet Respiratory Medicine
2022-03-01 • Lancet Respiratory Medicine
Journal Article
|Research
2013-02-13 • PLOS One
2013-02-13 • PLOS One
Innovative models of care are required to cope with the ever-increasing number of patients on antiretroviral therapy in the most affected countries. This study, in Khayelitsha, South Afr...
Journal Article
|Research
2011-02-17 • PLOS One
2011-02-17 • PLOS One
Loss to follow-up (LTF) challenges the reporting of antiretroviral treatment (ART) programmes, since it encompasses patients alive but lost to programme and deaths misclassified as LTF. ...
Journal Article
|Letter
2021-07-01 • International Journal of Tuberculosis and Lung Disease
2021-07-01 • International Journal of Tuberculosis and Lung Disease
Journal Article
|Commentary
2021-03-01 • Lancet Child and Adolescent Health
2021-03-01 • Lancet Child and Adolescent Health
Journal Article
|Commentary
2019-12-21 • Public Health Action
2019-12-21 • Public Health Action
Little is known about the barriers to post-exposure management of rifampicin-resistant tuberculosis (RR-TB) in older children and adolescents. We report on implementation lessons from a ...